HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amancio Carnero Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

1/2020Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features.
6/2019New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
12/2010The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amancio Carnero Research Topics

Disease

92Neoplasms (Cancer)
02/2024 - 06/2003
15Carcinogenesis
01/2023 - 08/2005
15Carcinoma (Carcinomatosis)
10/2020 - 08/2007
12Sarcoma (Soft Tissue Sarcoma)
10/2023 - 05/2005
9Breast Neoplasms (Breast Cancer)
01/2023 - 03/2007
9Neoplasm Metastasis (Metastasis)
11/2022 - 11/2012
9Adenocarcinoma
01/2019 - 03/2007
7Lung Neoplasms (Lung Cancer)
03/2020 - 01/2012
6Adenocarcinoma of Lung
09/2023 - 06/2014
6Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 07/2013
6Hematologic Neoplasms (Hematological Malignancy)
11/2016 - 04/2007
5Ovarian Neoplasms (Ovarian Cancer)
02/2024 - 06/2019
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 08/2013
4Inflammation (Inflammations)
10/2020 - 01/2013
3Colonic Neoplasms (Colon Cancer)
01/2018 - 12/2014
3Chronic Obstructive Pulmonary Disease (COPD)
12/2016 - 02/2013
3Multiple Myeloma
06/2015 - 08/2013
3Pathologic Processes
09/2014 - 01/2012
2Hypoxia (Hypoxemia)
02/2024 - 07/2021
2Frailty
01/2024 - 01/2020
2Rectal Neoplasms (Rectal Cancer)
01/2020 - 08/2018
2Laryngeal Neoplasms (Laryngeal Cancer)
05/2016 - 05/2015
2Lymphoma (Lymphomas)
01/2013 - 11/2007
2Melanoma (Melanoma, Malignant)
10/2007 - 06/2003
1Liposarcoma
10/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2023
1Drug-Related Side Effects and Adverse Reactions
10/2022
1Retinoblastoma (Glioblastoma, Retinal)
01/2021
1Malignant Mesothelioma
01/2020

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
09/2023 - 06/2003
17Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2012
13Membrane Proteins (Integral Membrane Proteins)IBA
08/2018 - 08/2007
11Messenger RNA (mRNA)IBA
10/2023 - 11/2007
8MicroRNAs (MicroRNA)IBA
01/2023 - 01/2012
7neurabinIBA
01/2023 - 06/2011
7EnzymesIBA
01/2022 - 11/2007
6PlatinumIBA
08/2021 - 05/2007
6Phosphotransferases (Kinase)IBA
08/2017 - 01/2010
5Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 05/2005
5proto-oncogene proteins pimIBA
08/2017 - 08/2012
4Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2023 - 05/2005
4NAD (NADH)IBA
03/2023 - 11/2017
4Cisplatin (Platino)FDA LinkGeneric
08/2018 - 05/2007
4CarcinogensIBA
11/2016 - 03/2007
3Transcription Factors (Transcription Factor)IBA
02/2024 - 09/2008
3Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2023 - 08/2008
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2023 - 09/2009
3HoloenzymesIBA
01/2023 - 01/2021
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 12/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 12/2014
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 09/2009
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2018 - 01/2013
3Bortezomib (Velcade)FDA Link
08/2018 - 06/2015
2Sirolimus (Rapamycin)FDA Link
01/2024 - 01/2020
2MaravirocFDA Link
01/2024 - 01/2020
2palbociclibIBA
10/2023 - 12/2015
2CytokinesIBA
11/2022 - 06/2003
2Oxygen (Dioxygen)IBA
11/2022 - 07/2021
2Cadherins (E-Cadherin)IBA
03/2020 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 02/2007
2olaparibIBA
01/2020 - 08/2018
2Proteasome InhibitorsIBA
08/2018 - 06/2015
2Adenosine Triphosphate (ATP)IBA
12/2017 - 12/2015
2ParaffinIBA
01/2017 - 12/2014
2LigandsIBA
12/2016 - 05/2007
2Dasatinib (BMS 354825)FDA Link
11/2016 - 05/2016
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2016 - 05/2016
2Estrogen ReceptorsIBA
12/2014 - 03/2007
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2014 - 01/2013
2Protein Isoforms (Isoforms)IBA
08/2012 - 09/2009
2Estrogen Receptor alphaIBA
12/2008 - 03/2007
2AminesIBA
10/2008 - 05/2007
2TrabectedinIBA
02/2007 - 05/2005
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
02/2024
1ChromatinIBA
02/2024
1TransposasesIBA
02/2024
1Interleukin-10 (Interleukin 10)IBA
01/2024
1Nucleic AcidsIBA
11/2022
1Therapeutic UsesIBA
01/2022
1SenotherapeuticsIBA
01/2022
1CateninsIBA
08/2021
1Protein Phosphatase 1IBA
01/2021
1NestinIBA
01/2021
1Small Interfering RNA (siRNA)IBA
11/2020
1Myosin-Light-Chain PhosphataseIBA
11/2020
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
03/2020
1Complement System Proteins (Complement)IBA
01/2020
1Plasminogen Activator Inhibitor 1IBA
01/2020
1AZD1208IBA
01/2020
1InterleukinsIBA
01/2020
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2019
1phospholipase D2IBA
01/2019

Therapy/Procedure

41Therapeutics
02/2024 - 11/2007
14Drug Therapy (Chemotherapy)
04/2022 - 11/2007
9Radiotherapy
04/2022 - 01/2013
3Adjuvant Chemotherapy
01/2020 - 12/2014
1Immunotherapy
10/2022
1Chronotherapy
10/2022
1Operative Surgical Procedures
01/2020